12 Health Care Stocks Moving In Monday's Pre-Market Session
I'm LongbridgeAI, I can summarize articles.In Monday's pre-market session, several healthcare stocks showed significant movement. Gainers included Advanced Biomed (+24.1%), Barinthus Biotherapeutics (+10.17%), HCW Biologics (+10.0%), Camp4 Therapeutics (+9.97%), Atara Biotherapeutics (+7.27%), and Genenta Science (+7.09%). Conversely, losers featured BioVie (-15.6%), GlucoTrack (-13.4%), Bluejay Diagnostics (-11.04%), Valion Bio (-10.94%), Elutia (-9.48%), and GRI Bio (-9.34%).
Gainers
- Advanced Biomed (NASDAQ:ADVB) shares rose 24.1% to $6.24 during Monday's pre-market session. The market value of their outstanding shares is at $8.2 million.
- Barinthus Biotherapeutics (NASDAQ:BRNS) shares rose 10.17% to $0.61. The market value of their outstanding shares is at $22.6 million.
- HCW Biologics (NASDAQ:HCWB) shares rose 10.0% to $4.4. The company's market cap stands at $6.3 million.
- Camp4 Therapeutics (NASDAQ:CAMP) stock rose 9.97% to $4.08. The market value of their outstanding shares is at $192.6 million.
- Atara Biotherapeutics (NASDAQ:ATRA) shares rose 7.27% to $9.0. The company's market cap stands at $75.5 million.
- Genenta Science (NASDAQ:GNTA) stock increased by 7.09% to $1.66. The market value of their outstanding shares is at $36.3 million.
Losers
- BioVie (NASDAQ:BIVI) shares decreased by 15.6% to $1.52 during Monday's pre-market session. The market value of their outstanding shares is at $13.5 million.
- GlucoTrack (NASDAQ:GCTK) shares declined by 13.4% to $0.43. The company's market cap stands at $3.2 million.
- Bluejay Diagnostics (NASDAQ:BJDX) stock decreased by 11.04% to $1.29. The company's market cap stands at $1.5 million.
- Valion Bio (NASDAQ:VBIO) shares decreased by 10.94% to $0.45. The market value of their outstanding shares is at $1.6 million.
- Elutia (NASDAQ:ELUT) shares fell 9.48% to $0.86. The market value of their outstanding shares is at $41.9 million.
- GRI Bio (NASDAQ:GRI) shares fell 9.34% to $1.36. The company's market cap stands at $2.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Login to unlock917characters for free
Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.